Key Segments:
By Product Type
-
Mandibular Advancement Devices (MADs)
-
Tongue Stabilizing Devices (TSDs)
-
Chin Straps
-
Nasal Devices
-
Positional Therapy Devices
By Material
-
Thermoplastic
-
Silicone
-
Acrylic
-
Rubber
By Distribution Channel
-
Online Stores
-
Retail Pharmacies
-
Specialty Sleep Clinics
-
Hospitals
By End User
-
Homecare Settings
-
Hospitals
-
Sleep Laboratories
-
Clinics
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The anti-snoring devices market size was estimated at USD 1.08 billion in 2025 and is expected to reach USD 2.57 billion by 2035, growing at a CAGR of 9.06% from 2026 to 2035.
The anti-snoring devices market is growing due to rising sleep apnea prevalence, increasing health awareness, and demand for non-invasive home-based solutions.
The US anti-snoring devices market is valued at USD 0.30 billion in 2025 and is expected to reach USD 0.69 billion by 2035, growing at a CAGR of 8.74%.
Mandibular Advancement Devices (MADs) lead the anti-snoring devices market with a 42.5% share, driven by proven effectiveness in repositioning the jaw to maintain an open airway.
North America dominates the anti-snoring devices market with a 38% share in 2025, fueled by high sleep disorder awareness, advanced healthcare infrastructure, and strong adoption of oral devices.